419 related articles for article (PubMed ID: 19269141)
1. Emerging fluoroquinolone-non-susceptible group A streptococci in two different paediatric populations.
Smeesters PR; Vergison A; Junior DC; Van Melderen L
Int J Antimicrob Agents; 2009 Jul; 34(1):44-9. PubMed ID: 19269141
[TBL] [Abstract][Full Text] [Related]
2. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
3. Increase in fluoroquinolone non-susceptibility among clinical Streptococcus pyogenes in Belgium during 2007-10.
Van Heirstraeten L; Leten G; Lammens C; Goossens H; Malhotra-Kumar S
J Antimicrob Chemother; 2012 Nov; 67(11):2602-5. PubMed ID: 22815354
[TBL] [Abstract][Full Text] [Related]
4. In vitro induction and selection of fluoroquinolone-resistant mutants of Streptococcus pyogenes strains with multiple emm types.
Billal DS; Fedorko DP; Yan SS; Hotomi M; Fujihara K; Nelson N; Yamanaka N
J Antimicrob Chemother; 2007 Jan; 59(1):28-34. PubMed ID: 17065188
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic reduced susceptibility of serotype 6 Streptococcus pyogenes to fluoroquinolone antibiotics.
Orscheln RC; Johnson DR; Olson SM; Presti RM; Martin JM; Kaplan EL; Storch GA
J Infect Dis; 2005 Apr; 191(8):1272-9. PubMed ID: 15776373
[TBL] [Abstract][Full Text] [Related]
6. Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes.
Malhotra-Kumar S; Lammens C; Chapelle S; Mallentjer C; Weyler J; Goossens H
J Antimicrob Chemother; 2005 Mar; 55(3):320-5. PubMed ID: 15705642
[TBL] [Abstract][Full Text] [Related]
7. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.
Beeton ML; Chalker VJ; Kotecha S; Spiller OB
J Antimicrob Chemother; 2009 Sep; 64(3):529-38. PubMed ID: 19567408
[TBL] [Abstract][Full Text] [Related]
8. Differences between Belgian and Brazilian group A Streptococcus epidemiologic landscape.
Smeesters PR; Vergison A; Campos D; de Aguiar E; Miendje Deyi VY; Van Melderen L
PLoS One; 2006 Dec; 1(1):e10. PubMed ID: 17183632
[TBL] [Abstract][Full Text] [Related]
9. Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.
Michos AG; Bakoula CG; Braoudaki M; Koutouzi FI; Roma ES; Pangalis A; Nikolopoulou G; Kirikou E; Syriopoulou VP
Diagn Microbiol Infect Dis; 2009 Jul; 64(3):295-9. PubMed ID: 19395219
[TBL] [Abstract][Full Text] [Related]
10. M protein gene (emm type) analysis of group A beta-hemolytic streptococci from Ethiopia reveals unique patterns.
Tewodros W; Kronvall G
J Clin Microbiol; 2005 Sep; 43(9):4369-76. PubMed ID: 16145079
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain.
Rivera A; Rebollo M; Sánchez F; Navarro F; Miró E; Mirelis B; Coll P
Clin Microbiol Infect; 2005 Sep; 11(9):759-61. PubMed ID: 16104992
[TBL] [Abstract][Full Text] [Related]
12. Seven-year surveillance of north american pediatric group a streptococcal pharyngitis isolates.
Shulman ST; Tanz RR; Dale JB; Beall B; Kabat W; Kabat K; Cederlund E; Patel D; Rippe J; Li Z; Sakota V;
Clin Infect Dis; 2009 Jul; 49(1):78-84. PubMed ID: 19480575
[TBL] [Abstract][Full Text] [Related]
13. Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity.
Albertí S; Cortés G; García-Rey C; Rubio C; Baquero F; García-Rodríguez JA; Bouza E; Aguilar L
Antimicrob Agents Chemother; 2005 Jan; 49(1):418-20. PubMed ID: 15616324
[TBL] [Abstract][Full Text] [Related]
14. Distribution of emm types among group A streptococcal isolates from Serbia.
Mijac V; Ranin L; Marković M; Heeg C; Reinert RR; Opavski N
Clin Microbiol Infect; 2010 Mar; 16(3):295-8. PubMed ID: 19519840
[TBL] [Abstract][Full Text] [Related]
15. Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme.
Canton R; Morosini M; Enright MC; Morrissey I
J Antimicrob Chemother; 2003 Dec; 52(6):944-52. PubMed ID: 14585861
[TBL] [Abstract][Full Text] [Related]
16. Genetic diversity of Group A Streptococcus M protein: implications for typing and vaccine development.
Smeesters PR; Mardulyn P; Vergison A; Leplae R; Van Melderen L
Vaccine; 2008 Oct; 26(46):5835-42. PubMed ID: 18789365
[TBL] [Abstract][Full Text] [Related]
17. Emergence of fluoroquinolone-resistant Streptococcus pyogenes in Japan by a point mutation leading to a new amino acid substitution.
Arai K; Hirakata Y; Yano H; Kanamori H; Endo S; Hirotani A; Abe Y; Nagasawa M; Kitagawa M; Aoyagi T; Hatta M; Yamada M; Nishimaki K; Takayama Y; Yamamoto N; Kunishima H; Kaku M
J Antimicrob Chemother; 2011 Mar; 66(3):494-8. PubMed ID: 21172783
[TBL] [Abstract][Full Text] [Related]
18. Associations of macrolide and fluoroquinolone resistance with molecular typing in Streptococcus pyogenes from invasive infections, 2010-2012.
Wajima T; Morozumi M; Chiba N; Shouji M; Iwata S; Sakata H; Ubukata K
Int J Antimicrob Agents; 2013 Nov; 42(5):447-9. PubMed ID: 23988719
[TBL] [Abstract][Full Text] [Related]
19. Outbreak of invasive group A streptococcal disease among children attending a day-care center.
Aguero J; Ortega-Mendi M; Eliecer Cano M; Gonzalez de Aledo A; Calvo J; Viloria L; Mellado P; Pelayo T; Fernandez-Rodriguez A; Martinez-Martinez L
Pediatr Infect Dis J; 2008 Jul; 27(7):602-4. PubMed ID: 18520444
[TBL] [Abstract][Full Text] [Related]
20. Decrease of erythromycin resistance in group A streptococci by change of emm distribution.
Koh EH; Kim S; Lee NY
Jpn J Infect Dis; 2008 Jul; 61(4):261-3. PubMed ID: 18653965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
